1673-422X
2015 Issue 12
Smac playing vital role in enhancing the sensitivity of cyclophosphamide and doxorubicin in breast cancer MCF-7 cell line
Cheng Liying;,Sun Tao;,Chen Wenqiang;,Meng Qingsong;
Cheng Liying;,Sun Tao;,Chen Wenqiang;,Meng Qingsong;
..............page:881-885
Effect and mechanism of CRISPR/Cas system on proliferation and apoptosis of human cervical cancer cells
Wang Ruiling;,Hu Zheng;,Xia Wei;,Wei Bo;,Ye Wanglian;,Zhu Hongfang;
Wang Ruiling;,Hu Zheng;,Xia Wei;,Wei Bo;,Ye Wanglian;,Zhu Hongfang;
..............page:886-890
Correlation study of the different expression changes of Ki-67 after neoadjuvant chemotherapy and chemotherapy curative effect for the different molecular classification breast cancers
wu xiu ping ;, liu fei ;, wu sai hong ;, ran wang jun ;, zeng de xue ;, zheng xiao yan ;, hu lian zuo ;, xie yuan fu ;, zhuo yan hong ;
wu xiu ping ;, liu fei ;, wu sai hong ;, ran wang jun ;, zeng de xue ;, zheng xiao yan ;, hu lian zuo ;, xie yuan fu ;, zhuo yan hong ;
..............page:891-895
Clinicopathological significance and expression of Numb and α-catenin in gastric carcinoma
Liu Xuefei;,Li Wenhui;,Xin Yan;
Liu Xuefei;,Li Wenhui;,Xin Yan;
..............page:896-899
Expressions and clinical significances of microRNA-126 and vascular endothelial growth factor in gastric carcinoma
Li Zhihan;,Zhang Xiliang;,Wang Wei;
Li Zhihan;,Zhang Xiliang;,Wang Wei;
..............page:900-902
Expression and clinical value of Pokemon in hepatocellular carcinoma
Zhang Quanle;,Xing Xizhi;,Li Fengyan;,Qin Yanhong;,Zhang Liying;
Zhang Quanle;,Xing Xizhi;,Li Fengyan;,Qin Yanhong;,Zhang Liying;
..............page:903-906
Panitumumab compared with cetuximab-irinotecan therapy in patients with KRAS wild-type metastatic colorectal cancer
hu hai feng ;, nian liang ;, sun xiao dong ;, qiao jian ;, duan wei ;, gao na ;, zhang zuo ;, liu ning ning ;, liu yi zuo ;
hu hai feng ;, nian liang ;, sun xiao dong ;, qiao jian ;, duan wei ;, gao na ;, zhang zuo ;, liu ning ning ;, liu yi zuo ;
..............page:907-910
Roles of cell signaling pathways in thyroid carcinoma
Xu Yingkai;,Hu Jie;,Liu Wei;
Xu Yingkai;,Hu Jie;,Liu Wei;
..............page:911-915
Neoadjuvant chemotherapy for locally advanced cancer
Liu Hui;,Rui Jing;
Liu Hui;,Rui Jing;
..............page:916-919
Medical therapy of bone metastases of breast cancer
Xie Xiaojuan;,Tong Zhongsheng;
Xie Xiaojuan;,Tong Zhongsheng;
..............page:920-923
Applications of the biomaker-detection technology guiding neoadjuvant therapy for advanced esophageal cancer
Li Chen;,Cheng Yufeng;
Li Chen;,Cheng Yufeng;
..............page:924-927
..............page:928-931
Clinical study on the radiosensitizer of esophageal carcinoma
Kang Mei;,Quan Xunfeng;
Kang Mei;,Quan Xunfeng;
..............page:932-935
Digestive tract reconstruction after proximal gastrectomy
Huang Ling;,Wang Xinbao;
Huang Ling;,Wang Xinbao;
..............page:936-938
Effect of IL-2 on primary hepatic carcinoma and its potential clinical value
Pang Jing;,Deng Zhihua;
Pang Jing;,Deng Zhihua;
..............page:939-941
Diagnosis and treatment of carcinoma of unknown primary
Li Zhenzhen;,Xie Conghua;
Li Zhenzhen;,Xie Conghua;
..............page:942-945
Pathogenesis, clinical evaluation and treatment of neuropathic cancer pain
Liu Weishuai;,Shao Yuejuan;,Wang Kun;
Liu Weishuai;,Shao Yuejuan;,Wang Kun;
..............page:946-949
..............page:950-951
nian qing nv xing ru xian shi xing shen jing nei fen mi ai 1 li
wang xiao lan ;, cao ming qian ;, zhang dian long ;
wang xiao lan ;, cao ming qian ;, zhang dian long ;
..............page:952-953
..............page:954